英文名稱 Anti-phospho-CPLA2 (Ser505)

中文名稱 磷酸化胞漿型磷脂酶A2抗體

濃 度 1mg/1ml

規 格 0.1ml/100μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應 Human, Mouse, Rat, Horse, Rabbit

產品類型 一抗 磷酸化抗體

研究領域 腫瘤 細胞生物 免疫學 信號轉導 轉錄調節因子

蛋白分子量 predicted molecular weight: 82kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthesised phosphopeptide derivedfrom human CPLA2 around the phosphorylation site of Ser505 [PL(p-S)PL]

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4

產品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -429 °C for oneyear.

別 名 CPLA2(phospho-Ser505); CPLA2(phospho-S505); p-CPLA2(Ser505); p-CPLA2 (S505); Calcium dependent phospholipid binding protein; CPLA2; cPLA2 alpha; cPLA2; Cytosolic phospholipase A2; Cytosolic phospholipase A2group IVA; Lysophospholipase; MGC126350; PA24A_HUMAN; Phosphatidylcholine 2acylhydrolase; Phosphatidylcholine 2-acylhydrolase; Phospholipase A2 group 4 A;Phospholipase A2 group IVA (cytosolic calcium dependent); Phospholipase A2group IVA; PhospholipaseA2; PLA2G4.